Doxycycline for the treatment of paronychia induced by the epidermal growth factor receptor inhibitor cetuximab

被引：42

作者：

Suh, KY

Kindler, HL

Medenica, M

Lacouture, M

机构：

[1] Univ Chicago, Dept Med, Dermatol Sect, Chicago, IL 60637 USA

[2] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA

[3] Northwestern Univ, Feinburg Sch Med, Dept Dermatol, Chicago, IL 60611 USA

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2006年 / 154卷 / 01期

关键词：

D O I：

10.1111/j.1365-2133.2005.07010.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：191 / 192

页数：3

共 10 条

[1]

Baran R, 1990, J DERMATOL TREAT, V1, P151

[2]

BLUMENTAL G, 1984, J AM ACAD DERMATOL, V4, P677

[3] Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225 [J].

Busam, KJ ;

Capodieci, P ;

Motzer, R ;

Kiehn, T ;

Phelan, D ;

Halpern, AC .

BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (06) :1169-1176

[4] Complications of therapy in cancer patients - Case 1. Paronychia and skin hyperpigmentation induced by gefitinib in advanced non-small-cell lung cancer [J].

Chang, GC ;

Yang, TY ;

Chen, KC ;

Yin, MC ;

Wang, RC ;

Lin, YC .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (22) :4646-4648

[5]

Golub L M, 1998, Adv Dent Res, V12, P12

[6]

Herbst Roy S, 2003, Clin Lung Cancer, V4, P366, DOI 10.3816/CLC.2003.n.016

[7] The promise of molecular targeted therapies: Protein kinase inhibitors in the treatment of cutaneous malignancies [J].

Kondapalli, L ;

Soltani, K ;

Lacouture, ME .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (02) :291-302

[8]

LEE CF, 1983, Q REV ECON BUS, V23, P6

[9] Practical management of patients with non-small-cell lung cancer treated with gefitinib [J].

Shah, NT ;

Kris, MG ;

Pao, W ;

Tyson, LB ;

Pizzo, BM ;

Heinemann, MH ;

Ben-Porat, L ;

Sachs, DL ;

Heelan, RT ;

Miller, VA .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (01) :165-174

[10]

Tosti A, 1999, BRIT J DERMATOL, V140, P1165

← 1 →